Update on Biosimilars in Asia. 2017

Wen-Chan Tsai
School of Medicine Kaohsiung Medical University, Department of Internal Medicine, Kaohsiung Medical University Hospital, 100 Tzyou 1st Road, Kaohsiung, Taiwan. d10153@ms14.hinet.net.

OBJECTIVE This review provides an update on the evolution of, manufacturing of, and regulations for biosimilars in Asian countries. RESULTS The use of biologics revolutionized the treatment of various diseases. However, the high cost of biologics remained unaffordable for most Asian patients and increases the financial burden of Asian governments. The development of biosimilars provides the best solution for this predicament. A great boom of biosimilars is developing in Asia. Hundreds of biopharmaceutical companies have established their manufacturing facilities and provide affordable products for Asian patients. Regulation guidelines and international harmonization are evolving. Better manufacturing quality and post-market pharmacovigilance are needed in Asia despite the rapid evolution of biosimilar development.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001208 Asia The largest of the continents. It was known to the Romans more specifically as what we know today as Asia Minor. The name comes from at least two possible sources: from the Assyrian asu (to rise) or from the Sanskrit usa (dawn), both with reference to its being the land of the rising sun, i.e., eastern as opposed to Europe, to the west. (From Webster's New Geographical Dictionary, 1988, p82 & Room, Brewer's Dictionary of Names, 1992, p34)
D017277 Drug Approval Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug. Drug Approval Process,New Drug Approval,Food and Drug Administration Drug Approval,Food and Drug Administration Drug Approval Process,New Drug Approval Process,Approval Process, Drug,Approval Processes, Drug,Approval, Drug,Approval, New Drug,Approvals, Drug,Approvals, New Drug,Drug Approval Processes,Drug Approval, New,Drug Approvals,Drug Approvals, New,New Drug Approvals,Process, Drug Approval,Processes, Drug Approval
D055808 Drug Discovery The process of finding chemicals for potential therapeutic use. Drug Prospecting,Discovery, Drug,Prospecting, Drug
D059451 Biosimilar Pharmaceuticals Biological products that are imitations but not exact replicas of innovator biological products. Biosimilar,Biosimilars,Follow-on Biologics,Subsequent Entry Biologics,Biologics, Follow-on,Biologics, Subsequent Entry,Follow on Biologics,Pharmaceuticals, Biosimilar

Related Publications

Wen-Chan Tsai
April 2017, Inflammopharmacology,
Wen-Chan Tsai
January 2023, Clinical pharmacology and therapeutics,
Wen-Chan Tsai
April 2024, Eye (London, England),
Wen-Chan Tsai
January 2021, Preparative biochemistry & biotechnology,
Wen-Chan Tsai
January 2017, Therapeutic innovation & regulatory science,
Wen-Chan Tsai
June 2017, Infection & chemotherapy,
Wen-Chan Tsai
January 1995, AIDS clinical review,
Wen-Chan Tsai
April 2021, American journal of ophthalmology,
Wen-Chan Tsai
January 2020, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases,
Wen-Chan Tsai
January 2013, Drug, healthcare and patient safety,
Copied contents to your clipboard!